有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | N-[(1-methylpiperidin-1-ium-4-ylidene)amino]-3-phenylsulfanylpropanamide | —— | C15H22N3OS+ |
|
—— | (1'S,5'R,6'R)-2'-amino-6'-(4-methylsulfanylphenyl)spiro[1,3-dioxolane-2,4'-3-azoniabicyclo[3.1.0]hex-2-ene]-1',5'-dicarbonitrile | —— | C16H15N4O2S+ |
|
—— | 2-[(3R)-1-methyl-2-oxopyrido[2,3-b][1,4]thiazin-3-yl]-N-[2-(4-methylpiperazin-1-yl)ethyl]acetamide | —— | C17H25N5O2S |
|
—— | 2-[(3S)-1-methyl-2-oxopyrido[2,3-b][1,4]thiazin-3-yl]-N-[2-(4-methylpiperazin-1-yl)ethyl]acetamide | —— | C17H25N5O2S |
|
—— | 2-[6-[(2R)-2-ethylpiperidin-1-yl]pyrimidin-4-yl]sulfanyl-1-morpholin-4-ylethanone | —— | C17H26N4O2S |
|
—— | 2-[6-[(2S)-2-ethylpiperidin-1-yl]pyrimidin-4-yl]sulfanyl-1-morpholin-4-ylethanone | —— | C17H26N4O2S |
|
—— | N-{4-[(2-chloro-4-pyrimidinyl)sulfanyl]phenyl}acetamide | —— | C12H10ClN3OS |
|
—— | 2-[[(4S,4aS,8aS)-2,4-diphenyl-4,4a,5,6,7,8-hexahydrothiochromen-8a-yl]sulfanyl]ethanamine | —— | C23H27NS2 |
|
—— | 2-[[(4S,4aS,8aR)-2,4-diphenyl-4,4a,5,6,7,8-hexahydrothiochromen-8a-yl]sulfanyl]ethylazanium | —— | C23H28NS2+ |
|
—— | 2-[[(4S,4aS,8aR)-2,4-diphenyl-4,4a,5,6,7,8-hexahydrothiochromen-8a-yl]sulfanyl]ethanamine | —— | C23H27NS2 |
|
—— | 2-[[(4S,4aS,8aS)-2,4-diphenyl-4,4a,5,6,7,8-hexahydrothiochromen-8a-yl]sulfanyl]ethylazanium | —— | C23H28NS2+ |
|
—— | methyl (4S)-2-methyl-4-(5-methyl-2-methylsulfanylthiophen-3-yl)-5-oxo-4a,6,7,8-tetrahydro-4H-quinoline-3-carboxylate | —— | C18H21NO3S2 |
|
—— | 3-(4-bromophenyl)sulfanyl-1-[4-[(3R)-1,1-dioxothiolan-3-yl]piperazin-1-yl]propan-1-one | —— | C17H23BrN2O3S2 |
|
—— | 3-(4-bromophenyl)sulfanyl-N-[3-[(2S,6S)-2,6-dimethylmorpholin-4-yl]propyl]propanamide | —— | C18H27BrN2O2S |
|
—— | methyl (5E)-2-methyl-5-[(4-methylsulfanylphenyl)methylidene]-4-oxo-3H-pyrrole-3-carboxylate | —— | C15H15NO3S |
|
—— | (2S)-N-ethyl-N-(2-methylprop-2-enyl)-2-[(5-pyrrolidin-1-yl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide | —— | C15H24N4OS2 |
|
—— | 3-propan-2-yl-5-[(1S)-1-(1,3-thiazol-2-ylsulfanyl)ethyl]-1,2,4-oxadiazole | —— | C10H13N3OS2 |
|
—— | 5-[3-(1,3-thiazol-2-ylsulfanyl)propyl]-3-thiophen-2-yl-1,2,4-oxadiazole | —— | C12H11N3OS3 |
|
—— | (2S)-N-benzyl-N-methyl-2-(1,3-thiazol-2-ylsulfanyl)propanamide | —— | C14H16N2OS2 |
|
—— | (2S)-3-methyl-1-morpholin-4-yl-2-(1,3-thiazol-2-ylsulfanyl)butan-1-one | —— | C12H18N2O2S2 |
|
—— | (2R)-1-(4-ethylpiperazin-1-yl)-2-(1,3-thiazol-2-ylsulfanyl)propan-1-one | —— | C12H19N3OS2 |
|
—— | (2R)-1-[(3S)-5-(4-chlorophenyl)-3-(furan-2-yl)-3,4-dihydropyrazol-2-yl]-2-(1,3-thiazol-2-ylsulfanyl)propan-1-one | —— | C19H16ClN3O2S2 |
|
—— | (2R)-3-methyl-1-morpholin-4-yl-2-[(5-pyrrolidin-1-yl-1,3,4-thiadiazol-2-yl)sulfanyl]butan-1-one | —— | C15H24N4O2S2 |
|
—— | N-[(2R)-6-methylheptan-2-yl]-2-[(5-pyrrolidin-1-yl-1,3,4-thiadiazol-2-yl)sulfanyl]acetamide | —— | C16H28N4OS2 |
|
—— | N-[[5-[(2S)-butan-2-yl]sulfanyl-4-butyl-1,2,4-triazol-3-yl]methyl]adamantane-1-carboxamide | —— | C22H36N4OS |
|
—— | N-[[5-[(2S)-butan-2-yl]sulfanyl-4-ethyl-1,2,4-triazol-3-yl]methyl]adamantane-1-carboxamide | —— | C20H32N4OS |
|
—— | N-[[5-[(2R)-butan-2-yl]sulfanyl-4-ethyl-1,2,4-triazol-3-yl]methyl]adamantane-1-carboxamide | —— | C20H32N4OS |
|
—— | (1S)-1-(3-bromophenyl)-2-[(5-pyrrolidin-1-yl-1,3,4-thiadiazol-2-yl)sulfanyl]ethanol | —— | C14H16BrN3OS2 |
|
—— | N-[[5-[(2R)-butan-2-yl]sulfanyl-4-butyl-1,2,4-triazol-3-yl]methyl]adamantane-1-carboxamide | —— | C22H36N4OS |
|
—— | N-[(2S)-heptan-2-yl]-2-(1-prop-2-enyltetrazol-5-yl)sulfanylacetamide | —— | C13H23N5OS |
|
—— | 5-[3-[(5-pyrrolidin-1-yl-1,3,4-thiadiazol-2-yl)sulfanyl]propyl]-3-thiophen-2-yl-1,2,4-oxadiazole | —— | C15H17N5OS3 |
|
—— | 3-propan-2-yl-5-[(1S)-1-[(5-pyrrolidin-1-yl-1,3,4-thiadiazol-2-yl)sulfanyl]ethyl]-1,2,4-oxadiazole | —— | C13H19N5OS2 |
|
—— | 5-[(3R)-1-[2-(3,4-dimethylphenyl)sulfanylethyl]piperidin-3-yl]-3-methyl-1,2,4-oxadiazole | —— | C18H25N3OS |
|
—— | (2R)-N-ethyl-N-(2-methylprop-2-enyl)-2-(1-prop-2-enyltetrazol-5-yl)sulfanylpropanamide | —— | C13H21N5OS |
|
—— | (2S)-3-methyl-1-morpholin-4-yl-2-(1-prop-2-enyltetrazol-5-yl)sulfanylbutan-1-one | —— | C13H21N5O2S |
|
—— | 5-[[(2R)-oxolan-2-yl]methylsulfanyl]-1-prop-2-enyltetrazole | —— | C9H14N4OS |
|
—— | (2S)-1-(4-ethylpiperazin-1-yl)-2-(1-prop-2-enyltetrazol-5-yl)sulfanylpropan-1-one | —— | C13H22N6OS |
|
—— | 2-[[(2R)-oxolan-2-yl]methylsulfanyl]-5-pyrrolidin-1-yl-1,3,4-thiadiazole | —— | C11H17N3OS2 |
|
—— | 2-(2-benzylsulfanyl-4-oxo-1H-pyrimidin-6-yl)-N-[[(2S)-oxolan-2-yl]methyl]acetamide | —— | C18H21N3O3S |
|
—— | 2-(2-benzylsulfanyl-4-oxo-1H-pyrimidin-6-yl)-N-[[(2R)-oxolan-2-yl]methyl]acetamide | —— | C18H21N3O3S |
|
—— | N-[5-[(2S)-butan-2-yl]sulfanyl-1,3,4-thiadiazol-2-yl]-3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carboxamide | —— | C17H17ClN4O2S2 |
|
—— | (7R)-5,5,7-trimethyl-2-sulfanylidene-[1,3]dithiolo[4,5-b][1,4]dithiepin-6-one | —— | C9H10OS5 |
|
—— | (7S)-5,5,7-trimethyl-2-sulfanylidene-[1,3]dithiolo[4,5-b][1,4]dithiepin-6-one | —— | C9H10OS5 |
|
—— | 4-amino-N'-[[4-(difluoromethylsulfanyl)phenyl]methoxy]-1-methyl-2-oxo-1-azaspiro[4.4]non-3-ene-3-carboximidamide | —— | C18H22F2N4O2S |
|
—— | (3R)-1-methyl-3-(2-oxo-2-pyrrolidin-1-ylethyl)pyrido[2,3-b][1,4]thiazin-2-one | —— | C14H17N3O2S |
|
—— | (3S)-1-methyl-3-(2-oxo-2-pyrrolidin-1-ylethyl)pyrido[2,3-b][1,4]thiazin-2-one | —— | C14H17N3O2S |
|
—— | (2R)-N-[(4-methylphenyl)methyl]-2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]-N-prop-2-ynylpropanamide | —— | C17H20N4OS |
|
—— | (2S)-2-(cyclopropylmethoxy)-N-[3-(4-fluorophenyl)sulfanylpropyl]propanamide | —— | C16H22FNO2S |
|
—— | (2S)-N-[[4-(difluoromethylsulfanyl)phenyl]methyl]-N-methyloxolane-2-carboxamide | —— | C14H17F2NO2S |
|
—— | ethyl (Z)-2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]sulfanyl-3-(dimethylamino)prop-2-enoate | —— | C13H14ClF3N2O2S |
|